HLS Therapeutics Price To Sales Ratio Over Time
| HLS Stock | CAD 5.00 0.03 0.60% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out HLS Therapeutics Performance and HLS Therapeutics Correlation. HLS |
Cross Equities Price To Sales Ratio Analysis
Compare HLS Therapeutics and related stocks such as Aptose Biosciences, Knight Therapeutics, and Medicenna Therapeutics Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APS | 362 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 194 | 184 |
| GUD | 1.1 K | 1.1 K | 1.1 K | 1.1 K | 1.1 K | 716 | 218 | 135 | 87.8675 | 22.3208 | 3.5337 | 2.7097 | 2.0273 | 1.6994 | 1.4531 | 1.38 |
| MDNA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PRN | 15.7437 | 15.7437 | 15.7437 | 15.7437 | 15.7437 | 15.7437 | 15.7437 | 15.7437 | 28.9009 | 38.6727 | 48.6682 | 33.5679 | 33.2155 | 24.6234 | 17.4061 | 33.11 |
HLS Therapeutics and related stocks such as Aptose Biosciences, Knight Therapeutics, and Medicenna Therapeutics Price To Sales Ratio description
Price to Sales Ratio is figured by comparing HLS Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on HLS Therapeutics sales, a figure that is much harder to manipulate than other HLS Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| HLS Therapeutics | HLS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 10 Carlson Court, |
| Exchange | Toronto Exchange |
CAD 5.0
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.